Goldman Sachs’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $762K | Buy |
347,868
+249,227
| +253% | +$546K | ﹤0.01% | 4016 |
|
|
2025
Q1 | $134K | Sell |
98,641
-72,951
| -43% | -$99.2K | ﹤0.01% | 4766 |
|
|
2024
Q4 | $228K | Buy |
171,592
+8,827
| +5% | +$11.7K | ﹤0.01% | 4615 |
|
|
2024
Q3 | $189K | Sell |
162,765
-34,194
| -17% | -$39.7K | ﹤0.01% | 4508 |
|
|
2024
Q2 | $262K | Sell |
196,959
-22,359
| -10% | -$29.7K | ﹤0.01% | 4267 |
|
|
2024
Q1 | $432K | Buy |
219,318
+107,674
| +96% | +$212K | ﹤0.01% | 4051 |
|
|
2023
Q4 | $157K | Buy |
111,644
+55,002
| +97% | +$77.6K | ﹤0.01% | 4386 |
|
|
2023
Q3 | $73.1K | Sell |
56,642
-5,451
| -9% | -$7.03K | ﹤0.01% | 4438 |
|
|
2023
Q2 | $107K | Sell |
62,093
-35,158
| -36% | -$60.5K | ﹤0.01% | 4557 |
|
|
2023
Q1 | $176K | Sell |
97,251
-12,604
| -11% | -$22.8K | ﹤0.01% | 4558 |
|
|
2022
Q4 | $292K | Sell |
109,855
-12,464
| -10% | -$33.2K | ﹤0.01% | 4366 |
|
|
2022
Q3 | $405K | Sell |
122,319
-16,842
| -12% | -$55.8K | ﹤0.01% | 4368 |
|
|
2022
Q2 | $507K | Buy |
139,161
+79,923
| +135% | +$291K | ﹤0.01% | 4368 |
|
|
2022
Q1 | $302K | Sell |
59,238
-93,886
| -61% | -$479K | ﹤0.01% | 4883 |
|
|
2021
Q4 | $1.17M | Buy |
+153,124
| New | +$1.17M | ﹤0.01% | 3906 |
|